Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases

3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases

US Patent 7906512 · Granted Mar 15, 2011

Estimated economic value: $166,719,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Back interface for rack shelf2025
NPR-B agonists2018
Methods of treating ophthalmic diseases using NPR-B agonists2017
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-relat2017
NPR-B agonists2017
RNAi-mediated inhibition of histamine receptor H1-related conditions2017
Cyclic peptide-based NPR-B agonists2016
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-relat2016
RNAi-mediated inhibition of tumor necrosis factor α-related conditions2016
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditio2016
RNAi-mediated inhibition of histamine receptor H1-related conditions2015
Topical ocular analgesic agents2015